Global X NASDAQ 100 Tail Risk ETF (QTR)
Market Closed
7 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
34. 35
+0.31
+0.9256%
$
3.59M Market Cap
0.25% Div Yield
28,600 Volume
$ 34.03
Previous Close Investors:
Want to track QTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%
FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 second quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $9,303,067 for the three months ended June 30, 2024, a 67% increase over gross revenues of $5,560,865 for same period in 2023.
Accesswire | 1 year ago
